We observed also that the plasma concentrations of MMP-2, MMP-9, TIMP-1, and TIMP-2 were significantly increased in the two subgroups in comparison with normal subjects, but in MS subjects with DM the values were higher than in nondiabetics (Table 2). This evidence concerns the gene TIMP1 and myeloid sarcoma.